Options for Inactivation, Adjuvant, and Route of Topical Administration of a Killed, Unencapsulated Pneumococcal Whole-Cell Vaccine
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
We previously reported that ethanol-killed cells of a noncapsulated strain of Streptococcus pneumoniae , given intranasally with cholera toxin as an adjuvant, protect rats against pneumonia and mice against colonization of the nasopharynx and middle ear by capsulated pneumococci of various serotypes. The acceleration of pneumococcal clearance from the nasopharynx in mice is CD4 + T cell-dependent and interleukin 17A (IL-17A) mediated and can be antibody independent. Here, anticipating human studies, we have demonstrated protection with a new vaccine strain expressing a nonhemolytic derivative of pneumolysin and grown in bovine-free culture medium. Killing the cells with chloroform, trichloroethylene, or beta-propiolactone—all used without postinactivation washing—produced more-potent immunogens than ethanol, and retention of soluble components released from the cells contributed to protection. Two sequential intranasal administrations of as little as 1 μg of protein (total of cellular and soluble combined) protected mice against nasopharyngeal challenge with pneumococci. Nontoxic single and double mutants of Escherichia coli heat-labile toxin were effective as mucosal adjuvants. Protection was induced by the sublingual and buccal routes, albeit requiring larger doses than when given intranasally. Protection was likewise induced transdermally with sonicates of the killed-cell preparation. Thus, this whole-cell antigen can be made and administered in a variety of ways to suit the manufacturer and the vaccination program and is potentially a solution to the need for a low-cost vaccine to reduce the burden of childhood pneumococcal disease in low-income countries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
O'Brien, K. L., Wolfson, L. J., Watt, J. P., Henkle, E., Deloria-Knoll, M., McCall, N., Lee, E., Mulholland, K., Levine, O. S., & Cherian, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61204-6 · Cited by 2,398 · cited 1×
“Streptococcus pneumoniae (pneumococcus) imparts a major disease burden among children in low-income countries (27).”
BackgroundCD4 + T cells mediate antibody-independent acquired immunity to pneumococcal colonization
Malley, R., Trzcinski, K., Srivastava, A., Thompson, C. M., Anderson, P. W., & Lipsitch, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501254102 · Cited by 346
Self-citation
Cited by
Effect of vaccine administration modality on immunogenicity and efficacy
Zhang, L., Wang, W., & Wang, S. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.1081067 · Cited by 255
Norton, E. B., Lawson, L. B., Freytag, L. C., & Clements, J. D. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00538-10 · Cited by 221
“To date, our published studies have shown that dmLT functions as an oral adjuvant in a Helicobacter vaccine (34) and as a sublingual or buccal adjuvant in a whole-cell pneumococcal vaccine in mice (23).”
BackgroundSelf-citationThe Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLT
Clements, J. D., & Norton, E. B. (2018) · mSphere · doi:10.1128/msphere.00215-18 · Cited by 177
Self-citationWhite, J. A., Blum, J. S., Hosken, N. A., Marshak, J. O., Duncan, L., Zhu, C., Norton, E. B., Clements, J. D., Koelle, D. M., Chen, D., et al. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.32253 · Cited by 51
Self-citation
Metadata
- Authors
- Lu, Y.-J., Yadav, P., Clements, J. D., Forte, S., Srivastava, A., Thompson, C. M., Seid, R., Look, J., Alderson, M., Tate, A., Maisonneuve, J.-F., Robertson, G., Anderson, P. W., & Malley, R.
- Venue
- Clinical and Vaccine Immunology
- Publisher
- American Society for Microbiology
- Published
- 2010-06
- Volume
- 17
- Issue
- 6
- Pages
- 1005-1012
- ISSN
- 1556-679X (ISSN-L)
- 1556-6811
- OpenAlex
- W2130103410
- Cited by
- 101
- References
- 2
- FWCI
- 6.08
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Options for Inactivation, Adjuvant, and Route of Topical Administration of a Killed, Unencapsulated Pneumococcal Whole-Cell Vaccine. https://app.cochat.ai/papers/10.1128/cvi.00036-10
- The paper
- Lu, Y.-J., Yadav, P., Clements, J. D., Forte, S., Srivastava, A., Thompson, C. M., Seid, R., Look, J., Alderson, M., Tate, A., Maisonneuve, J.-F., Robertson, G., Anderson, P. W., & Malley, R. (2010). Options for Inactivation, Adjuvant, and Route of Topical Administration of a Killed, Unencapsulated Pneumococcal Whole-Cell Vaccine. Clinical and Vaccine Immunology. https://doi.org/10.1128/cvi.00036-10
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.